- Home
- BLNK vs OPTN Comparison
BLNK vs OPTN Comparison
Compare BLNK & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- OPTN
- Stock Information
- Founded
- BLNK 2009
- OPTN 2010
- Country
- BLNK United States
- OPTN United States
- Employees
- BLNK N/A
- OPTN N/A
- Industry
- BLNK Industrial Specialties
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- OPTN Health Care
- Exchange
- BLNK Nasdaq
- OPTN Nasdaq
- Market Cap
- BLNK 105.2M
- OPTN 92.8M
- IPO Year
- BLNK N/A
- OPTN 2017
- Fundamental
- Price
- BLNK $0.84
- OPTN $9.39
- Analyst Decision
- BLNK Buy
- OPTN Hold
- Analyst Count
- BLNK 8
- OPTN 3
- Target Price
- BLNK $3.19
- OPTN $9.00
- AVG Volume (30 Days)
- BLNK 2.8M
- OPTN 32.1K
- Earning Date
- BLNK 05-12-2025
- OPTN 05-20-2025
- Dividend Yield
- BLNK N/A
- OPTN N/A
- EPS Growth
- BLNK N/A
- OPTN N/A
- EPS
- BLNK N/A
- OPTN N/A
- Revenue
- BLNK $126,197,000.00
- OPTN $78,226,000.00
- Revenue This Year
- BLNK $1.49
- OPTN $30.49
- Revenue Next Year
- BLNK $31.89
- OPTN $13.51
- P/E Ratio
- BLNK N/A
- OPTN N/A
- Revenue Growth
- BLNK N/A
- OPTN 10.20
- 52 Week Low
- BLNK $0.63
- OPTN $4.82
- 52 Week High
- BLNK $3.75
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- BLNK 56.46
- OPTN 76.14
- Support Level
- BLNK $0.71
- OPTN $9.37
- Resistance Level
- BLNK $0.77
- OPTN $9.45
- Average True Range (ATR)
- BLNK 0.05
- OPTN 0.08
- MACD
- BLNK 0.02
- OPTN -0.07
- Stochastic Oscillator
- BLNK 81.34
- OPTN 80.71
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.